P&K Skin Research Center Co., Ltd. (KOSDAQ:347740)

P&K Skin Research Center Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	7,390	5,816	4,813	7,130
Depreciation & Amortization	1,923	1,848	1,735	1,468
Loss (Gain) From Sale of Assets	-	0.31	0	0.97
Loss (Gain) From Sale of Investments	-1,592	-712.69	-140.01	185.18
Stock-Based Compensation	-	15.84	65.71	65.98
Provision & Write-off of Bad Debts	-15.15	61.72	80.73	48.15
Other Operating Activities	50.16	682.78	-1,263	-439.34
Change in Accounts Receivable	-303.33	236.27	146.84	-753.86
Change in Other Net Operating Assets	604.99	1,083	110.94	-198.24
Operating Cash Flow	8,057	9,032	5,549	7,507
Operating Cash Flow Growth	16.26%	62.77%	-26.08%	-
Capital Expenditures	-1,637	-622.12	-1,526	-1,230
Sale (Purchase) of Intangibles	-	-	-33.34	-126.01
Investment in Securities	-7,266	-8,102	6,468	-2,457
Other Investing Activities	-117.17	-	-786.62	-406.26
Investing Cash Flow	-9,020	-8,874	972.22	-4,320
Long-Term Debt Repaid	-	-394.27	-372.54	-318.02
Net Debt Issued (Repaid)	-425.33	-394.27	-372.54	-318.02
Issuance of Common Stock	-	-	-	1,495
Repurchase of Common Stock	-	-2,386	-610.61	-
Dividends Paid	-976.98	-714.68	-872.08	-892.93
Other Financing Activities	-	-	149	-0
Financing Cash Flow	-1,402	-3,495	-1,706	283.73
Foreign Exchange Rate Adjustments	0.44	0.52	0.01	0.03
Net Cash Flow	-2,365	-3,336	4,815	3,471
Free Cash Flow	6,420	8,410	4,023	6,277
Free Cash Flow Growth	10.60%	109.06%	-35.91%	-
Free Cash Flow Margin	29.46%	47.12%	27.10%	34.96%
Free Cash Flow Per Share	222.30	289.65	134.13	210.50
Cash Interest Paid	29.53	24.34	30.48	23.93
Cash Income Tax Paid	1,260	681.74	1,329	1,178
Levered Free Cash Flow	3,709	3,915	-2,996	-
Unlevered Free Cash Flow	3,732	3,931	-2,976	-
Change in Working Capital	301.67	1,319	257.78	-952.1

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.